A novel dipeptidyl peptidase IV inhibitor DA-1229 ameliorates streptozotocin-induced diabetes by increasing β-cell replication and neogenesis-Reference-Cited by-同舟云学术

A novel dipeptidyl peptidase IV inhibitor DA-1229 ameliorates streptozotocin-induced diabetes by increasing β-cell replication and neogenesis

Published:2011-01 Issue:1 Volume:91 Page:72-79
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Cho Jae Min,Jang Hye Won,Cheon Hwanju,Jeong Yeon Taek,Kim Do-Hoon,Lim Yu-Mi,Choi Song-hyen,Yang Eun-kyoung,Shin Chang-Yell,Son Moon Ho,Kim Soon Hoe,Kim Heung-Jae,Lee Myung-Shik

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference34 articles.

1. Type 1 diabetes: new perspectives on disease pathogenesis and treatment;Atkinson;Lancet,2001

2. Redefining the clinical management of type 2 diabetes: matching therapy to pathophysiology;Gerich;Eur J Clin Invest,2002

3. Glucotoxicity and beta-cell failure in type 2 diabetes mellitus;Kaiser;J Pediatr Endocrinol Metab,2003

4. Biology of incretins: GLP-1 and GIP;Baggio;Gastroenterology,2007

5. Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats;Xu;Diabetes,1999

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hesperidin activates the GLP-1R/cAMP-CREB/IRS2/PDX1 pathway to promote transdifferentiation of islet α cells into β cells Across the spectrum;Heliyon;2024-08

2. Harnessing beta cell regeneration biology for diabetes therapy;Trends in Endocrinology & Metabolism;2024-04

3. Role of β‐cell autophagy in β‐cell physiology and the development of diabetes;Journal of Diabetes Investigation;2024-03-12

4. An update on pancreatic regeneration mechanisms: Searching for paths to a cure for type 2 diabetes;Molecular Metabolism;2023-08

5. Physiology, pharmacology and prospects for dipeptidilpeptidase-4 inhibitors use;Pharmacy & Pharmacology;2023-04-28